Traws Pharma, Inc. (TRAW) Insider Trading
Directors, officers and holders of more than 10% of TRAW report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 72 transactions on file: 4 with code P, 0 with code S and 46 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 9, 2026 | Shoemaker Mary Teresa | Director | A Award | 14,150 | Not measured | Not measured |
| Jul 9, 2026 | Redfield Robert | Chief Medical Officer | A Award | 84,000 | Not measured | Not measured |
| Jul 9, 2026 | Dukes Iain D. | Chief Executive Officer | A Award | 274,000 | Not measured | Not measured |
| Jul 9, 2026 | STOVER JACK E | Director | A Award | 14,150 | Not measured | Not measured |
| Jul 9, 2026 | CAUTREELS WERNER | Director | A Award | 14,150 | Not measured | Not measured |
| Jul 9, 2026 | Pauza Charles David | Chief Science Officer Virology | A Award | 97,000 | Not measured | Not measured |
| Jul 9, 2026 | Savchuk Nikolay | Chief Operating Officer | A Award | 93,000 | Not measured | Not measured |
| Jul 9, 2026 | Parker Charles Nolan | Chief Financial Officer | A Award | 90,000 | Not measured | Not measured |
| Jul 9, 2026 | Leaman John Harold | Director | A Award | 14,150 | Not measured | Not measured |
| Jul 9, 2026 | Clarke Trafford | Director | A Award | 14,150 | Not measured | Not measured |
| Apr 16, 2026 | ORBIMED ADVISORS LLC | 10% Owner | P Purchase | 597,729 | Not measured | Not measured |
| Apr 16, 2026 | ORBIMED ADVISORS LLC | 10% Owner | P Purchase | 597,729 | $1.67 | $998,207 |
| Apr 16, 2026 | ORBIMED ADVISORS LLC | 10% Owner | P Purchase | 1,793,187 | Not measured | Not measured |
| Apr 16, 2026 | ORBIMED ADVISORS LLC | 10% Owner | P Purchase | 597,729 | Not measured | Not measured |
| Mar 8, 2026 | Shoemaker Mary Teresa | Director | A Award | 33,435 | Not measured | Not measured |
| Mar 8, 2026 | Redfield Robert | Chief Medical Officer | A Award | 108,854 | Not measured | Not measured |
| Mar 8, 2026 | Savchuk Nikolay | Chief Operating Officer | A Award | 96,899 | Not measured | Not measured |
| Mar 8, 2026 | Dukes Iain D. | Chief Executive Officer | A Award | 231,336 | Not measured | Not measured |
| Mar 8, 2026 | Clarke Trafford | Director | A Award | 33,435 | Not measured | Not measured |
| Mar 8, 2026 | Leaman John Harold | Director | A Award | 33,435 | Not measured | Not measured |
| Mar 8, 2026 | CAUTREELS WERNER | Director | A Award | 31,258 | Not measured | Not measured |
| Mar 8, 2026 | Pauza Charles David | Chief Science Officer Virology | A Award | 118,367 | Not measured | Not measured |
| Mar 8, 2026 | STOVER JACK E | Director | A Award | 33,435 | Not measured | Not measured |
| Mar 8, 2026 | Parker Charles Nolan | Chief Financial Officer | A Award | 104,544 | Not measured | Not measured |
| Dec 12, 2025 | Pauza Charles David | Chief Science Officer Virology | A Award | 18,471 | Not measured | Not measured |
| Dec 12, 2025 | Savchuk Nikolay | Chief Operating Officer | A Award | 16,419 | Not measured | Not measured |
| Dec 12, 2025 | Parker Charles Nolan | Chief Financial Officer | A Award | 15,393 | Not measured | Not measured |
| Dec 12, 2025 | Redfield Robert | Chief Medical Officer | A Award | 16,419 | Not measured | Not measured |
| Dec 12, 2025 | Leaman John Harold | Director | A Award | 4,058 | Not measured | Not measured |
| Dec 12, 2025 | Clarke Trafford | Director | A Award | 6,157 | Not measured | Not measured |
| Dec 12, 2025 | CAUTREELS WERNER | Director | A Award | 4,874 | Not measured | Not measured |
| Dec 12, 2025 | Shoemaker Mary Teresa | Director | A Award | 6,157 | Not measured | Not measured |
| Dec 12, 2025 | STOVER JACK E | Director | A Award | 6,157 | Not measured | Not measured |
| Dec 12, 2025 | Dukes Iain D. | Chief Executive Officer | A Award | 36,943 | Not measured | Not measured |
| Dec 12, 2025 | Pauza Charles David | Chief Science Officer Virology | A Award | 73,886 | Not measured | Not measured |
| Dec 12, 2025 | Savchuk Nikolay | Chief Operating Officer | A Award | 65,676 | Not measured | Not measured |
| Dec 12, 2025 | Parker Charles Nolan | Chief Financial Officer | A Award | 61,571 | Not measured | Not measured |
| Dec 12, 2025 | Redfield Robert | Chief Medical Officer | A Award | 65,676 | Not measured | Not measured |
| Dec 12, 2025 | Leaman John Harold | Director | A Award | 16,234 | Not measured | Not measured |
| Dec 12, 2025 | Clarke Trafford | Director | A Award | 24,629 | Not measured | Not measured |
| Dec 12, 2025 | CAUTREELS WERNER | Director | A Award | 19,496 | Not measured | Not measured |
| Dec 12, 2025 | Shoemaker Mary Teresa | Director | A Award | 24,629 | Not measured | Not measured |
| Dec 12, 2025 | STOVER JACK E | Director | A Award | 24,629 | Not measured | Not measured |
| Dec 12, 2025 | Dukes Iain D. | Chief Executive Officer | A Award | 147,771 | Not measured | Not measured |
| Nov 21, 2025 | Leaman John Harold | Director | A Award | 12,770 | Not measured | Not measured |
| Oct 12, 2025 | Savchuk Nikolay | Chief Operating Officer | A Award | 22,435 | Not measured | Not measured |
| Oct 12, 2025 | CAUTREELS WERNER | Director | A Award | 11,530 | Not measured | Not measured |
| Oct 12, 2025 | STOVER JACK E | Director | A Award | 11,530 | Not measured | Not measured |
| Oct 12, 2025 | Clarke Trafford | Director | A Award | 11,530 | Not measured | Not measured |
| Oct 12, 2025 | Dukes Iain D. | Chief Executive Officer | A Award | 64,839 | Not measured | Not measured |
The full Form 4 history is on the TRAW company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.